Metacell activates cells such as
PRP (Platelet-Rich Plasma),
SVF (Stromal Vascular Fraction),
and stem cell concentrates,
and is the latest solution that
activates 2,993 billion autologous exosomes per 1ml of
a patient’s own plasma.
By utilizing Photo-Thermal
BioModulation (PBM) technology, which applies five types of
light and heat, Metacell extracts
autologous exosomes from the
patient’s own plasma,
maximizes their yield,
and ensures biologically safe
and optimal results.
Based on this innovative solution,
Metacell provides a variety of
biologically safe technologies
with reliability.